For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240426:nRSZ1846Ma&default-theme=true
RNS Number : 1846M Wilmington PLC 26 April 2024
26 April 2024
Wilmington plc
APM sold for €26 million
Wilmington plc (LSE: WIL, 'Wilmington', 'the Group'), the provider of data,
information, education and training in the global Governance, Risk and
Compliance markets, has sold its French healthcare business, APM, for an
enterprise value of €26 million in cash, subject to customary working
capital adjustments, to Philia Medical Editions SAS, a subsidiary of Europa
Group.
For the year ended 30 June 2023, APM had gross assets of €9.6 million and
reported a profit before tax of €2.3 million. The proceeds of the sale will
be used for general corporate purposes.
Mark Milner, Chief Executive Officer of Wilmington, said
"This sale reflects our continued and active management of our portfolio as we
assess the potential of each business to exhibit the six common Wilmington
characteristics that we recognise as key drivers of organic revenue growth and
profitability improvement."
Marc Doncieux, Chairman and co-Founder of Europa Group, said
"APM's entry into Europa Group is a major asset in consolidating our position
as the French leader in training and health information. APM is a key player
in our market, whose reputation for excellence and independence is perfectly
in line with Europa Group's global strategy. We are delighted to welcome them
on board!"
For further information, contact:
Wilmington plc 020 7490 0049
Mark Milner, Chief Executive Officer
Guy Millward, Chief Financial Officer
Meare Consulting 07990 858548
Adrian Duffield
Notes to Editors
Wilmington plc is the recognised knowledge leader and partner of choice for
data, information, education and training in the global Governance, Risk and
Compliance (GRC) markets. Wilmington employs close to 1,000 people and sells
to around 120 countries. Wilmington is listed on the main market of the London
Stock Exchange
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DISUNONRSBUSURR